Hubei Goto Biopharm Group Co., Ltd. (SHE:300966)
China · Delayed Price · Currency is CNY 29.15
+0.48 (1.67%)
Jul 15, 2026, 3:06 PM CST
Hubei Goto Biopharm Group Market Cap
Hubei Goto Biopharm Group has a market cap or net worth of 3.27 billion as of July 15, 2026. Its market cap has increased by 59.40% in one year.
Market Cap
3.27B
Enterprise Value
4.60B
Revenue
628.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.15
Market Cap Chart
Since April 9, 2021, Hubei Goto Biopharm Group's market cap has decreased from 6.57B to 3.27B, a decrease of -50.16%. That is a compound annual growth rate of -12.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 3.27B | 44.50% |
| Dec 31, 2025 | 2.27B | 21.86% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
| Apr 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Scitop Bio-tech | 3.85B |
| Hinova Pharmaceuticals | 3.82B |
| Lifecome Biochemistry | 3.79B |
| Shanghai Shen Lian Biomedical | 3.73B |
| Beijing Bohui Innovation Biotechnology Group | 3.72B |
| Assure Tech (Hangzhou) | 3.69B |
| Boji Medical Technology | 3.63B |
| Pulike Biological Engineering | 3.49B |